MAGEB5
gene geneOn this page
Also known as MAGE-B5CT3.3
Summary
MAGEB5 (MAGE family member B5, HGNC:23795) is a protein-coding gene on chromosome Xp21.3, encoding Melanoma-associated antigen B5 (Q9BZ81).
Predicted to be involved in negative regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 347541 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001271752
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23795 |
| Approved symbol | MAGEB5 |
| Name | MAGE family member B5 |
| Location | Xp21.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MAGE-B5, CT3.3 |
| Ensembl gene | ENSG00000188408 |
| Ensembl biotype | protein_coding |
| OMIM | 300466 |
| Entrez | 347541 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000602297
RefSeq mRNA: 1 — MANE Select: NM_001271752
NM_001271752
CCDS: CCDS65233
Canonical transcript exons
ENST00000602297 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003296873 | 26217085 | 26218270 |
| ENSE00003435263 | 26216169 | 26216198 |
Expression profiles
Bgee: expression breadth tissue_specific, 3 present calls, max score 40.78.
Top tissues by expression
127 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 40.78 | gold quality |
| testis | UBERON:0000473 | 40.34 | gold quality |
| sural nerve | UBERON:0015488 | 39.18 | gold quality |
| bone marrow cell | CL:0002092 | 38.42 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| right testis | UBERON:0004534 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| bone marrow | UBERON:0002371 | 32.90 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| liver | UBERON:0002107 | 29.13 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| gall bladder | UBERON:0002110 | 28.78 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 27.56 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| leukocyte | CL:0000738 | 26.67 | gold quality |
| monocyte | CL:0000576 | 26.58 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| urinary bladder | UBERON:0001255 | 25.72 | gold quality |
| blood | UBERON:0000178 | 25.70 | gold quality |
| muscle of leg | UBERON:0001383 | 25.01 | gold quality |
| primary visual cortex | UBERON:0002436 | 24.61 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 24.08 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.15 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
10 targeting MAGEB5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-6832-3P | 99.52 | 70.44 | 1726 |
| HSA-MIR-138-2-3P | 98.91 | 68.33 | 1643 |
| HSA-MIR-605-5P | 98.79 | 68.24 | 1161 |
| HSA-MIR-188-5P | 97.89 | 67.01 | 756 |
| HSA-MIR-6866-3P | 97.38 | 66.94 | 748 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ndnl2 | ENSDARG00000058212 |
| mus_musculus | Mageb5 | ENSMUSG00000061392 |
| mus_musculus | Mageb5b | ENSMUSG00000064129 |
| rattus_norvegicus | Mageb5 | ENSRNOG00000003110 |
| drosophila_melanogaster | MAGE | FBGN0037481 |
Paralogs (37): MAGEC2 (ENSG00000046774), TRO (ENSG00000067445), MAGEB2 (ENSG00000099399), MAGED2 (ENSG00000102316), MAGEB4 (ENSG00000120289), MAGEA9 (ENSG00000123584), MAGEA10 (ENSG00000124260), MAGEA4 (ENSG00000147381), MAGED4 (ENSG00000154545), MAGEC1 (ENSG00000155495), MAGEA8 (ENSG00000156009), MAGEC3 (ENSG00000165509), MAGEB6 (ENSG00000176746), MAGEB18 (ENSG00000176774), MAGEF1 (ENSG00000177383), MAGEB10 (ENSG00000177689), MAGED1 (ENSG00000179222), NDN (ENSG00000182636), MAGEB17 (ENSG00000182798), MAGEA2B (ENSG00000183305), NSMCE3 (ENSG00000185115), MAGEA11 (ENSG00000185247), MAGEE2 (ENSG00000186675), MAGED4B (ENSG00000187243), MAGEH1 (ENSG00000187601), MAGEB16 (ENSG00000189023), MAGEA6 (ENSG00000197172), MAGEA1 (ENSG00000198681), MAGEB3 (ENSG00000198798), MAGEE1 (ENSG00000198934), MAGEA12 (ENSG00000213401), MAGEB1 (ENSG00000214107), MAGEA3 (ENSG00000221867), MAGEB6B (ENSG00000232030), MAGEL2 (ENSG00000254585), MAGEA9B (ENSG00000267978), MAGEA2 (ENSG00000268606)
Protein
Protein identifiers
Melanoma-associated antigen B5 — Q9BZ81 (reviewed: Q9BZ81)
Alternative names: Cancer/testis antigen 3.3, MAGE-B5 antigen
All UniProt accessions (1): Q9BZ81
UniProt curated annotations — full annotation on UniProt →
Tissue specificity. Expressed in testis. Not expressed in other normal tissues, but is expressed in tumors of different histological origins.
RefSeq proteins (1): NP_001258681* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002190 | MHD_dom | Domain |
| IPR037445 | MAGE | Family |
| IPR041898 | MAGE_WH1 | Homologous_superfamily |
| IPR041899 | MAGE_WH2 | Homologous_superfamily |
Pfam: PF01454
UniProt features (5 total): compositionally biased region 2, chain 1, domain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BZ81-F1 | 80.80 | 0.48 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 17 (showing top):
chrXp21, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, MIR4795_3P, GSE13306_TREG_VS_TCONV_SPLEEN_UP, GSE27786_CD8_TCELL_VS_NKTCELL_DN, GSE27786_NKCELL_VS_NKTCELL_DN, GOBP_NEGATIVE_REGULATION_OF_RNA_BIOSYNTHETIC_PROCESS, GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_UP, GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN, GSE8835_HEALTHY_VS_CLL_CD4_TCELL_DN, GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_DN, GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_DN, GSE24972_WT_VS_IRF8_KO_SPLEEN_FOLLICULAR_BCELL_UP, GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_KO_DN
GO Biological Process (1): negative regulation of transcription by RNA polymerase II (GO:0000122)
GO Molecular Function (0):
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of transcription by RNA polymerase II | 1 |
| transcription by RNA polymerase II | 1 |
| negative regulation of DNA-templated transcription | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
268 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MAGEB5 | C9orf153 | Q5TBE3 | 541 |
| MAGEB5 | OR1M1 | Q8NGA1 | 507 |
| MAGEB5 | ANKRD13C-DT | Q9XRX5 | 506 |
| MAGEB5 | F2Z2I4 | F2Z2I4 | 418 |
| MAGEB5 | TRIM42 | Q8IWZ5 | 410 |
| MAGEB5 | CCDC125 | Q86Z20 | 400 |
| MAGEB5 | HHLA1 | C9JL84 | 399 |
| MAGEB5 | FAM81A | Q8TBF8 | 394 |
| MAGEB5 | NUP210L | Q5VU65 | 377 |
| MAGEB5 | GAGE4 | P0DSO3 | 370 |
| MAGEB5 | DNHD1 | Q96M86 | 348 |
| MAGEB5 | SDE2 | Q6IQ49 | 337 |
| MAGEB5 | CSAG1 | Q6PB30 | 336 |
| MAGEB5 | MAGEC3 | Q8TD91 | 328 |
| MAGEB5 | CCDC33 | Q8N5R6 | 324 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MAGEB5 | MYH1 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (1): MAGEB5 (Proximity Label-MS)
ESM2 similar proteins: A0A0J9YX57, A1A5P9, A2A368, A2A9R3, A8MXT2, B2KFW1, O15479, O15480, O15481, O15553, P0C6Y7, P10073, P17040, P25233, P43355, P43356, P43357, P43358, P43360, P43362, P43363, P43364, P43366, Q13342, Q16666, Q4R998, Q5PPP4, Q5RD14, Q6AY37, Q6PCZ4, Q8BQR7, Q8IWY8, Q8IX06, Q8N660, Q8N7X4, Q8TD90, Q96DU7, Q96LZ2, Q96M61, Q99608
Diamond homologs: A0A0J9YX57, A1A5P9, A2A368, A2A9R3, A6NCF6, A6QLI5, A8MXT2, O15479, O15480, O15481, O60732, P25233, P43355, P43356, P43357, P43358, P43360, P43361, P43362, P43363, P43364, P43365, P43366, Q12816, Q4R998, Q5PPP4, Q5RFC2, Q6AY37, Q6ITT4, Q6PCZ4, Q8BQR7, Q8N7X4, Q8TD90, Q8TD91, Q96JG8, Q96LZ2, Q96M61, Q96MG7, Q99608, Q9BE18
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
220 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:26217084:GA:G | acceptor_gain | 0.9600 |
| X:26216194:GACAG:G | donor_loss | 0.9000 |
| X:26216195:ACAG:A | donor_loss | 0.9000 |
| X:26216196:CAGG:C | donor_loss | 0.9000 |
| X:26216197:AG:A | donor_loss | 0.9000 |
| X:26216198:GG:G | donor_loss | 0.9000 |
| X:26216199:G:A | donor_loss | 0.9000 |
| X:26216200:T:TC | donor_loss | 0.9000 |
| X:26216198:GGT:G | donor_gain | 0.8900 |
| X:26216196:CAGGT:C | donor_gain | 0.8800 |
| X:26216197:AGGTA:A | donor_gain | 0.8800 |
| X:26216199:GT:G | donor_gain | 0.8800 |
| X:26216200:T:TG | donor_gain | 0.8800 |
| X:26216201:AA:A | donor_loss | 0.8800 |
| X:26216195:ACAGG:A | donor_gain | 0.8400 |
| X:26217083:A:AG | acceptor_gain | 0.8300 |
| X:26217084:G:GG | acceptor_gain | 0.8300 |
| X:26216201:A:AC | donor_gain | 0.8100 |
| X:26216202:A:AC | donor_gain | 0.7600 |
| X:26217230:GGGGA:G | acceptor_gain | 0.7300 |
| X:26216203:G:C | donor_gain | 0.7200 |
| X:26217229:T:A | acceptor_gain | 0.7000 |
| X:26217229:TGGGG:T | acceptor_gain | 0.6700 |
| X:26216199:G:GG | donor_gain | 0.6600 |
| X:26216202:AGAA:A | donor_loss | 0.6500 |
| X:26217028:AGT:A | acceptor_gain | 0.6500 |
| X:26217029:GTG:G | acceptor_gain | 0.6500 |
| X:26217028:A:AG | acceptor_gain | 0.6200 |
| X:26217029:G:GG | acceptor_gain | 0.6200 |
| X:26217079:TATCA:T | acceptor_loss | 0.6100 |
AlphaMissense
1836 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:26217578:T:C | F93L | 0.903 |
| X:26217580:T:A | F93L | 0.903 |
| X:26217580:T:G | F93L | 0.903 |
| X:26217464:T:C | F55L | 0.863 |
| X:26217466:C:A | F55L | 0.863 |
| X:26217466:C:G | F55L | 0.863 |
| X:26217449:T:C | F50L | 0.859 |
| X:26217451:C:A | F50L | 0.859 |
| X:26217451:C:G | F50L | 0.859 |
| X:26217533:T:C | F78L | 0.833 |
| X:26217535:T:A | F78L | 0.833 |
| X:26217535:T:G | F78L | 0.833 |
| X:26217905:T:C | F202L | 0.825 |
| X:26217907:C:A | F202L | 0.825 |
| X:26217907:C:G | F202L | 0.825 |
| X:26217995:T:C | F232L | 0.804 |
| X:26217997:C:A | F232L | 0.804 |
| X:26217997:C:G | F232L | 0.804 |
| X:26217764:T:C | F155L | 0.766 |
| X:26217766:T:A | F155L | 0.766 |
| X:26217766:T:G | F155L | 0.766 |
| X:26217943:G:C | K214N | 0.735 |
| X:26217943:G:T | K214N | 0.735 |
| X:26217722:T:C | F141L | 0.710 |
| X:26217724:C:A | F141L | 0.710 |
| X:26217724:C:G | F141L | 0.710 |
| X:26217911:T:A | W204R | 0.704 |
| X:26217911:T:C | W204R | 0.704 |
| X:26217632:A:C | S111R | 0.686 |
| X:26217634:C:A | S111R | 0.686 |
dbSNP variants (sampled 300 via entrez): RS1002507335 (X:26214480 T>A,C), RS1003643226 (X:26217875 G>C), RS1003705237 (X:26216880 T>C), RS1004475157 (X:26214304 T>C), RS1008316514 (X:26216148 G>A), RS1010317152 (X:26216794 C>T), RS1010668004 (X:26216217 A>G), RS1010723268 (X:26217476 C>G), RS1011696379 (X:26215844 T>C), RS1011726397 (X:26214427 A>G), RS1011951050 (X:26216818 T>C), RS1012917697 (X:26215364 A>G,T), RS1014171460 (X:26217482 A>AT), RS1014638986 (X:26217924 C>T), RS1014740138 (X:26216999 T>C)
Disease associations
OMIM: gene MIM:300466 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.